معرفی
Ianthe Pitout is a Research Fellow and Associate Lecturer at the Personalised Medicine Centre within the Health Futures Institute at Murdoch University. As an early career molecular geneticist with 10 years of experience spanning academic and industry settings, she specializes in RNA-targeted therapeutics for degenerative diseases and leads the Oligo Therapeutics laboratory alongside Emeritus Professor Sue Fletcher.
Her educational background includes:
- Doctor of Philosophy in Molecular Genetics (2015-2019) from Murdoch University, Perth, Australia
- BSc Hons in BioMedical Science (2004-2008) from University of KwaZulu-Natal, Durban, South Africa
Dr. Pitout's research centers on designing and evaluating splice-switching antisense oligonucleotides for translational applications targeting motor neuron disease (including amyotrophic lateral sclerosis), inherited blindness, and other neurodegenerative conditions. Her work integrates molecular genetics with therapeutic development, emphasizing the transition from laboratory discovery to clinical implementation through antisense oligonucleotide technologies.
Her recognition includes:
- Western Australian Innovator of the Year award (2021) from the Government of Western Australia
Dr. Pitout maintains active leadership in the Oligo Therapeutics laboratory, driving innovation in RNA therapeutics. While the source material does not specify student advising activities or grant funding details, her role as laboratory lead indicates significant research management responsibilities within Murdoch University's Personalised Medicine Centre (formerly Centre for Molecular Medicine and Innovative Therapeutics).